N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide

C13H18N4O2 — CID 103221777

IUPACN-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide
SMILESO=C(Cn1ncc(NCC2CC2)cc1=O)NC1CC1
InChIInChI=1S/C13H18N4O2/c18-12(16-10-3-4-10)8-17-13(19)5-11(7-15-17)14-6-9-1-2-9/h5,7,9-10,14H,1-4,6,8H2,(H,16,18)
InChIKeyGCAXMVJDLZILRG-UHFFFAOYSA-N
MW262.31 g/mol
LogP0.34
Rot. Bonds6

About N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide

N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide (PubChem CID 103221777) has the molecular formula C13H18N4O2 and a molecular weight of 262.31 g/mol. Its IUPAC name is N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide.

Molecular Properties

Compound NameN-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide
PubChem CID103221777
Molecular FormulaC13H18N4O2
Molecular Weight262.31 g/mol
Exact Mass262.14
IUPAC NameN-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide
SMILESO=C(Cn1ncc(NCC2CC2)cc1=O)NC1CC1
InChIInChI=1S/C13H18N4O2/c18-12(16-10-3-4-10)8-17-13(19)5-11(7-15-17)14-6-9-1-2-9/h5,7,9-10,14H,1-4,6,8H2,(H,16,18)
InChIKeyGCAXMVJDLZILRG-UHFFFAOYSA-N
XLogP0.34
TPSA76.02 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500262.31
LogP ≤ 50.34
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide
CID 103221884
N-cyclopropyl-2-[4-(methylamino)-6-oxopyridazin-1-yl]acetamide
CID 103218488
2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide
CID 103221823
N-cyclohexyl-2-[6-oxo-4-(propan-2-ylamino)pyridazin-1-yl]acetamide
CID 103219584
5-(cyclopropylmethylamino)-2-(3-hydroxypropyl)pyridazin-3-one
CID 103221824
2-[4-(cyclopentylmethylamino)pyrazol-1-yl]-N-cyclopropylacetamide
CID 62069655
5-(cyclopropylmethylamino)-2-[(4-iodophenyl)methyl]pyridazin-3-one
CID 103221865
2-[(4-bromophenyl)methyl]-5-(cyclopropylmethylamino)pyridazin-3-one
CID 103221923
2-[4-(2-aminoethoxy)-6-oxopyridazin-1-yl]-N-cyclohexylacetamide
CID 103222868
5-(cyclopropylmethylamino)-2-[2-(2-methylimidazol-1-yl)ethyl]pyridazin-3-one
CID 103221754
2-[4-(3-aminopropoxy)-6-oxopyridazin-1-yl]-N-cyclopentylacetamide
CID 103223192
2-[(2-chlorophenyl)methyl]-5-(cyclopropylmethylamino)pyridazin-3-one
CID 103221743

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide?
The IUPAC name of N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide (CID 103221777) is N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide.
What is the SMILES notation for N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide?
The canonical SMILES for N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide is O=C(Cn1ncc(NCC2CC2)cc1=O)NC1CC1.
What is the InChIKey of N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide?
The InChIKey is GCAXMVJDLZILRG-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H18N4O2/c18-12(16-10-3-4-10)8-17-13(19)5-11(7-15-17)14-6-9-1-2-9/h5,7,9-10,14H,1-4,6,8H2,(H,16,18).
What are the key properties of N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide?
N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide has a molecular weight of 262.31 g/mol, XLogP of 0.34, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-2-[4-(cyclopropylmethylamino)-6-oxopyridazin-1-yl]acetamide is sourced from PubChem (CID 103221777), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).